Suppr超能文献

60岁以上人群的亚临床甲状腺功能减退与认知功能:一项系统评价和荟萃分析。

Subclinical hypothyroidism and cognitive function in people over 60 years: a systematic review and meta-analysis.

作者信息

Akintola Abimbola A, Jansen Steffy W, van Bodegom David, van der Grond Jeroen, Westendorp Rudi G, de Craen Anton J M, van Heemst Diana

机构信息

Department of Gerontology and Geriatrics, Leiden University Medical Center Leiden, Netherlands.

Leyden Academy on Vitality and Ageing Leiden, Netherlands.

出版信息

Front Aging Neurosci. 2015 Aug 11;7:150. doi: 10.3389/fnagi.2015.00150. eCollection 2015.

Abstract

Subclinical hypothyroidism (SCH), defined as elevated thyroid stimulating hormone (TSH) and normal thyroid hormone levels, and cognitive impairment are both common in older people. While the relation between overt hypothyroidism and cognitive impairment is well established, data on the association between SCH and cognitive impairment are conflicting. This systematic review and meta-analysis was performed to assess available evidence on the association of SCH with cognition in community dwelling, relatively healthy older adults. PubMed, EMBASE, Web of Science, COCHRANE, CINAHL, PsycINFO, and Academic Search Premier (January 1966 to April 1, 2015) were searched without language restrictions, as were references of key articles, for studies on the association between SCH and cognition in older adults (>60 years). These studies were reviewed by two independent reviewers according to predefined criteria for eligibility and methodological quality, and data were extracted using standardized forms. Of the 844 reports initially identified, 270 remained after exclusion of duplicates. Of the 270, 15 studies comprising 19,944 subjects, of whom 1,199 had subclinical hypothyroidism were included. Data from the 15 studies was pooled, and meta-analyzed cross-sectionally for global cognition [assessed by Mini-Mental State Examination (MMSE)], executive function, and memory, using random effects models. Pooled effect size (ES) for MMSE was -0.01 (95% CI -0.09, 0.08), with heterogeneity (I (2)) of 55.1%. Pooled ES was < 0.001 (95% CI -0.10, 0.09) for executive function (I (2) = 13.5%), and 0.01 (95% CI -0.12, 0.14) for memory (I (2) = 46.9%). In addition, prospective analysis including four studies showed pooled ES of 0.033 (95% CI -0.001 - 0.067) for MMSE (I (2) < 0.001%), indicating that subclinical hypothyroidism was not significantly associated with accelerated cognitive decline. This systematic review and meta-analysis provides no evidence that supports an association between SCH and cognitive impairment in relatively healthy older adults.

摘要

亚临床甲状腺功能减退症(SCH)定义为促甲状腺激素(TSH)升高而甲状腺激素水平正常,在老年人中较为常见,认知障碍亦是如此。虽然临床甲状腺功能减退症与认知障碍之间的关系已得到充分证实,但关于SCH与认知障碍之间关联的数据却相互矛盾。本系统评价和荟萃分析旨在评估关于社区居住的相对健康老年人中SCH与认知功能关联的现有证据。检索了PubMed、EMBASE、科学网、Cochrane图书馆、护理学与健康领域数据库、心理学文摘数据库以及学术搜索高级版(1966年1月至2015年4月1日),检索无语言限制,同时检索了关键文章的参考文献,以查找关于老年人(>60岁)中SCH与认知功能关联的研究。两名独立评审员根据预先确定的纳入标准和方法学质量对这些研究进行了评审,并使用标准化表格提取数据。在最初识别的844篇报告中,排除重复项后还剩270篇。在这270篇中,纳入了15项研究,共19944名受试者,其中1199人患有亚临床甲状腺功能减退症。汇总了这15项研究的数据,并使用随机效应模型对整体认知功能[通过简易精神状态检查表(MMSE)评估]、执行功能和记忆进行横断面荟萃分析。MMSE的合并效应量(ES)为-0.01(95%置信区间-0.09,0.08),异质性(I²)为55.1%。执行功能的合并ES<0.001(95%置信区间-0.10,0.09)(I² = 13.5%),记忆的合并ES为0.01(95%置信区间-0.12,0.14)(I² = 46.9%)。此外,包括四项研究的前瞻性分析显示,MMSE的合并ES为0.033(95%置信区间-0.001 - 0.067)(I²<0.001%),表明亚临床甲状腺功能减退症与认知功能加速衰退无显著关联。本系统评价和荟萃分析没有提供证据支持相对健康的老年人中SCH与认知障碍之间存在关联。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6ac/4531303/7bb50bd10ff6/fnagi-07-00150-g0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验